海南海药(000566) - 2017 Q1 - 季度财报

Financial Performance - Revenue for Q1 2017 was CNY 406,547,813.82, an increase of 8.44% compared to CNY 374,898,472.34 in the same period last year[8] - Net profit attributable to shareholders was CNY 66,143,165.23, reflecting a growth of 12.10% from CNY 59,004,856.79 year-over-year[8] - Net profit excluding non-recurring items was CNY 55,810,513.26, up 9.74% from CNY 50,854,839.67 in the previous year[8] - The weighted average return on equity decreased to 1.21%, down 1.33% from 2.54% in the previous year[8] Cash Flow - The net cash flow from operating activities was CNY -67,112,348.58, a significant decline of 547.53% compared to CNY 14,996,123.26 in the same period last year[8] - The company reported a net cash outflow from operating activities of ¥67,112,348.58, a decline of 547.53% compared to the previous year[21] - The net cash flow from financing activities increased by 1140.11% to ¥790,461,970.19, mainly due to new borrowings and the issuance of short-term financing bonds[23] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 10,397,794,318.21, an increase of 8.23% from CNY 9,607,288,032.75 at the end of the previous year[8] - Net assets attributable to shareholders were CNY 5,494,856,458.41, a slight increase of 1.22% from CNY 5,428,698,921.89[8] - The company's interest receivables increased by 115.36% from the beginning of the year to a balance of ¥10,146,286.30, primarily due to the accrual of interest on time deposits[21] - Long-term equity investments rose by 102.47% to ¥502,226,504.82, attributed to investments in several companies including Yancheng Haiyao Fengkang Investment Management[21] - Prepayments decreased by 50.38% to ¥14,942,710.01, mainly due to a reduction in advance payments for goods[21] - Other payables decreased by 38.99% to ¥105,546,327.15, primarily due to the payment of previously accrued sales expenses[21] Shareholder Information - The total number of shareholders at the end of the reporting period was 39,337[12] - The largest shareholder, Shenzhen Nanfang Tongzheng Investment Co., Ltd., held 34.08% of the shares, amounting to 455,355,676 shares[13] Investments and Income - The company reported non-operating income from government subsidies amounting to CNY 3,049,241.93[9] - Investment income increased by 127.96% to ¥4,120,404.90, mainly due to increased income from entrusted financial management of idle raised funds[21] - The company did not engage in any securities or derivative investments during the reporting period[29][30] Future Plans - The company plans to publicly issue corporate bonds with a scale not exceeding ¥1.7 billion, which has been approved by the China Securities Regulatory Commission[24] - The actual controller is planning a partial tender offer to increase his shareholding, proposing to acquire 133,597,926 shares at a price of ¥14.50 per share, representing 10% of the total share capital[26]